Current Illinois CancerCare Clinical Trals



Testing the Addition of Nivolumab to Chemotherapy for Patients With Metastatic Anal Cancer


Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

EAY191 – S3 (JIT)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Search Again

WordPress PopUp Plugin